Low PET Myocardial Flow Reserve Predicts Outcomes in Chronic Coronary Syndrome
A retrospective single-center study of 168 patients with suspected or established chronic coronary syndrome examined whether uncorrected global myocardial flow reserve (MFR) below 2.0 on 13N-ammonia PET predicted a composite of death, non-fatal myocardial infarction, heart-failure hospitalization, or malignant ventricular arrhythmia. The study reported that MFR below 2.0 was independently associated with this endpoint (hazard ratio 4.52), including in patients without baseline heart failure, and that rate-pressure-product correction reclassified 52 patients, mostly downward, altering risk stratification. The authors state these findings support reporting the uncorrected flow reserve value alongside any corrected value.
Most relevant for: Patients with suspected or established chronic coronary syndrome undergoing myocardial perfusion PET imaging.
Read the original at European Journal of Nuclear Medicine and Molecular ImagingSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More nuclear medicine updates
- New PET-based method images Ac-225 therapy with higher SNR than SPECTSep 30, 2026
- Open-Source Deep Learning Pipeline Automates PET-Only Tumor SegmentationSep 30, 2026
- New PET tracer targets human CD68 to image macrophagesSep 28, 2026
- PSMA-PET detects more oligometastatic prostate cancer than conventional imagingSep 28, 2026
- Quantitative flow by CZT-SPECT predicts cardiovascular events independentlySep 25, 2026